Post-PCI Chest Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with unstable angina chronic coronary syndrome or coronary microcirculation disease who undergo elective or emergency coronary percutaneous coronary intervention (PCI). 2.Aged 18 to 80 years old regardless of gender. 3.Provided written informed consent and voluntarily agreed to participate in the study. 4.Capable of independently completing questionnaires and able to perform activities of daily living (ADLs) without assistance.
Exclusion criteria
Exclusion criteria: 1.Patients with malignant tumors or severe hematological disorders; severe liver dysfunction defined as alanine transaminase (ALT) or aspartate transaminase (AST) > 2× the upper limit of normal range or those with Child-Pugh class B/C cirrhosis; severe renal dysfunction defined as estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m² or receiving dialysis. 2.Participants who have participated in or are scheduled to participate in another clinical trial within the past 1 month. 3.Pregnant or lactating women. 4.Patients with poor compliance as judged by investigators deemed unable to complete the trial. 5.Patients with known allergies to the components of Chinese herbal decoctions or patent medicines required for syndrome differentiation and treatment or their excipients. 6.Individuals who refuse to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seattle Angina Questionnaire (SAQ) Score;36-Item Short Form Health Survey (SF-36) Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Composite cardiovascular endpoints(cardiogenic death, all-cause mortality, acute myocardial infarction, repeat coronary revascularization, stroke, hospitalization for unstable angina, and heart failure); | — |
Countries
China
Contacts
Xiyuan Hospital China Academy of Chinese Medical Sciences